The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
4R program results: What is the impact of 4R care delivery model on patient self-management and which patients benefited?
 
Julia Rachel Trosman
Honoraria - Genentech
Consulting or Advisory Role - Genentech (Inst); Merck (Inst); NCCN/Pfizer (Inst)
Speakers' Bureau - Genentech (Inst)
Travel, Accommodations, Expenses - Genentech
 
Christine B. Weldon
Consulting or Advisory Role - Genentech (Inst)
Speakers' Bureau - Genentech
Research Funding - Merck (Inst); National Comprehensive Cancer Network (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Genentech (Inst)
 
Della F. Makower
No Relationships to Disclose
 
Bruce D. Rapkin
No Relationships to Disclose
 
Moreen Bozier
No Relationships to Disclose
 
Claudia Beth Perez
No Relationships to Disclose
 
Swati Kulkarni
No Relationships to Disclose
 
Cathleen M. Schaeffer
No Relationships to Disclose
 
Kent Hoskins
Research Funding - Abbvie (Inst); Merck Sharp & Dohme (Inst); Novartis Pharmaceuticals UK Ltd.; Novartis Pharmaceuticals UK Ltd. (Inst); Pfizer (Inst)
 
Christopher Gallagher
Consulting or Advisory Role - Daiichi Sankyo; Seagen
 
Shelly S. Lo
No Relationships to Disclose
 
Cathy Grace-Louthen
No Relationships to Disclose
 
Alyssa Throckmorton
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Exactech (I); Zimmer BioMet (I)
Patents, Royalties, Other Intellectual Property - Biomet Zimmer, Exactech (I)
Travel, Accommodations, Expenses - Exactech (I)
 
Editha A. Krueger
No Relationships to Disclose
 
Jennifer Van Horn
No Relationships to Disclose
 
Arliene Ravelo
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Elaine Yu
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Lidia Schapira
Consulting or Advisory Role - Blue Note Therapeutics; Rubedo Life Sciences
 
Al Bowen Benson
Consulting or Advisory Role - Array BioPharma; Association for Value-Based Cancer Care (AVBCC); Bayer; Bristol-Myers Squibb; Dava Oncology; Genentech; Guardant Health; Harborside Press; LSK BioPharma; Merck Sharp & Dohme; Merck Sharp & Dohme; NCCN; Novartis; Pfizer; PrECOG; Research to Practice; Springer; TYME
Research Funding - Acerta Pharma/AstraZeneca (Inst); Advanced Accelerator Applications (Inst); Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); ECOG-ACRIN (Inst); Infinity Pharmaceuticals (Inst); Infinity Pharmaceuticals (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); PrECOG (Inst); Rafael Pharmaceuticals (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Association of Community Cancer Centers (ACCC); Astellas Pharma; Bayer; Bristol-Myers Squibb; CancerCare; Genentech/Roche; Guardant Health; Lilly/ImClone; Lynx Group; Merck Sharp & Dohme; MJH Healthcare Holdings, LLC; NCCN; North American Neuroendocrine Tumor Society; NPAF/PAF
 
William John Gradishar
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Pfizer; Puma Biotechnology